Key result
CLOSURE-AF trial prompts reevaluation of post-LAAC antithrombotic therapy.
Answers are grounded in this paper and cite their sources.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Yamauchi et al. (2026) studied this question. Antithrombotic therapy after left atrial appendage closure requires reevaluation in light of the CLOSURE-AF trial.
Synapse has enriched 10 related papers. Consider them for comparative context: